Cargando…
Prognostic Significance of Sarcomatoid Differentiation in Patients With Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
BACKGROUND: To date, the prognostic value of sarcomatoid differentiation in patients having metastatic renal cell carcinoma (mRCC) remains inconclusive. A systematic review and meta-analysis were conducted. MATERIALS AND METHODS: Relevant literatures were obtained from PubMed, Embase, and Cochrane L...
Autores principales: | Zhi, Hong, Feng, Meiling, Liu, Suo, Na, Ta, Zhang, Nandong, BiLiGe, WuEn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578539/ https://www.ncbi.nlm.nih.gov/pubmed/33134181 http://dx.doi.org/10.3389/fonc.2020.591001 |
Ejemplares similares
-
Case report: Significant benefits of tislelizumab combined with anlotinib in first-line treatment of metastatic renal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation
por: Zhu, Shibin, et al.
Publicado: (2022) -
Lymphangitic Retroperitoneal Carcinomatosis Occurring From Metastatic Sarcomatoid Chromophobe Renal Cell Carcinoma
por: Alimchandani, Meghna, et al.
Publicado: (2014) -
Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
por: Zhou, Yulin, et al.
Publicado: (2023) -
Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?
por: Adashek, Jacob J., et al.
Publicado: (2021) -
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
por: Noguchi, Go, et al.
Publicado: (2018)